INSMED INC shareholders Q3 2023

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.

INSMED INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 70,335$1,775,9590.79%
ESSEX INVESTMENT MANAGEMENT CO LLC 148,419$3,747,5800.61%
TANG CAPITAL MANAGEMENT LLC 166,203$4,196,6260.59%
Parkman Healthcare Partners LLC 125,000$3,156,2500.58%
SAMLYN CAPITAL, LLC 1,381,057$34,871,6900.57%
Soleus Capital Management, L.P. 218,000$5,504,5000.51%
Ikarian Capital, LLC 154,900$3,911,2260.47%
Nebula Research & Development LLC 27,867$703,6420.37%
RICE HALL JAMES & ASSOCIATES, LLC 224,465$5,667,7410.36%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4,241,935$107,108,8590.36%
GW&K Investment Management, LLC 1,352,269$34,1450.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 40,100$1,012,1240.34%
Long Focus Capital Management, LLC 371,649$9,384,1370.34%
EFG Asset Management (North America) Corp. 52,693$1,330,2350.32%
EAM Investors, LLC 64,558$1,630,0900.32%
OAK RIDGE INVESTMENTS LLC 95,523$2,411,9560.31%
Eventide Asset Management 635,185$16,038,4210.29%
Hennion & Walsh Asset Management, Inc. 171,006$4,317,9020.28%
Knights of Columbus Asset Advisors LLC 113,796$2,873,3490.26%
PEREGRINE CAPITAL MANAGEMENT LLC 340,125$8,588,1560.26%
External links

This page lists INSMED INC's shareholders in Q3 2023. To view INSMED INC's shareholder history, click here.